Global Pharmaceuticals & Biotech Top Stock Picks from Analysts

Rapid Micro Biosystems

Market Cap: US$133.2m

A life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally.

Aldeyra Therapeutics

Market Cap: US$130.6m

A biotechnology company, discovers and develops therapies designed to treat immune-mediated and metabolic diseases.

Scancell Holdings

Market Cap: UK£97.6m

A clinical stage biopharmaceutical company, engages in the discovery and development of novel immunotherapies and vaccines for the treatment of cancer and infectious disease.

TerrAscend

Market Cap: CA$178.2m

TerrAscend Corp. cultivates, produces, and sells cannabis products in Canada and the United States.

StemRIM

Market Cap: JP¥18.8b

A biotechnology company, develops regeneration medicines for the treatment of intractable diseases.

Photocure

Market Cap: NOK 1.3b

Engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products.

Xspray Pharma

Market Cap: SEK 1.2b

A pharmaceutical company, engages in the development of protein kinase inhibitors for targeted cancer treatments in Sweden.

ADC Therapeutics

Market Cap: US$126.0m

Provides antibody drug conjugate (ADC) technology platform to transform the treatment paradigm for patients with hematologic malignancies and solid tumors.

Greenwich LifeSciences

Market Cap: US$125.2m

A clinical-stage biopharmaceutical company, develops novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers.

Whan In PharmLtd

Market Cap: ₩176.3b

Manufactures and sells various pharmaceuticals products in South Korea.

Tango Therapeutics

Market Cap: US$123.2m

A precision oncology company, focuses on the discovery and development of drugs in defined patient populations with unmet medical need.

scPharmaceuticals

Market Cap: US$122.7m

A pharmaceutical company, focuses on developing and commercializing products to optimize the delivery of infused therapies and patient care.

T.Man Pharmaceutical

Market Cap: ฿4.0b

Manufactures and sells pharmaceuticals and health care products in Thailand.

Editas Medicine

Market Cap: US$121.4m

A clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases.

Tonix Pharmaceuticals Holding

Market Cap: US$121.2m

A biopharmaceutical company, focuses on developing and commercializing therapeutics to treat and prevent human disease.

Macrogen

Market Cap: ₩171.3b

Provides precision medicine and bio-engineering healthcare services in Korea and internationally.

Fate Therapeutics

Market Cap: US$119.2m

A clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders in the United States and internationally.

Protara Therapeutics

Market Cap: US$119.1m

A clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases.

Alpha Cognition

Market Cap: US$119.0m

A clinical stage biopharmaceutical company, engages in the development of treatments for Alzheimer’s disease and amyotrophic lateral sclerosis (ALS).

Theratechnologies

Market Cap: CA$166.0m

A biopharmaceutical company, focuses on the commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe.

Lyell Immunopharma

Market Cap: US$118.1m

A clinical-stage cell therapy company, develops chimeric antigen receptor (CAR) T-cell product candidates for patients with hematologic malignancies and solid tumors.

Compugen

Market Cap: US$117.8m

A clinical-stage therapeutic discovery and development company, engages in the research, development, and commercialization of therapeutics and product candidates in Israel, the United States, and Europe.

Alector

Market Cap: US$117.0m

A late-stage clinical biotechnology company, develops therapies that is focused on counteracting the devastating progression of neurodegenerative diseases.

MPH Health Care

Market Cap: €101.9m

An investment company, engages in the healthcare business in Germany.

Vigil Neuroscience

Market Cap: US$112.9m

A clinical-stage biotechnology company, focuses on developing treatments for rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel immune cells of the brain in the United States.

Enanta Pharmaceuticals

Market Cap: US$112.4m

A biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases.

Coherus BioSciences

Market Cap: US$112.3m

A biopharmaceutical company, researches, develops, and commercializes immunotherapies to treat cancer in the United States.

Genelux

Market Cap: US$110.4m

A clinical-stage biopharmaceutical company, focuses on developing oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types.

Seer

Market Cap: US$110.0m

A life sciences company, develops and commercializes products to decode the biology of the proteome.

Nektar Therapeutics

Market Cap: US$109.6m

A biopharmaceutical company, focuses on discovering and developing therapies that selectively modulate the immune system to treat autoimmune disorders in the United States and internationally.

InflaRx

Market Cap: US$108.8m

A clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology in Germany and the United States.

Cellectis

Market Cap: €97.3m

A clinical stage biotechnological company, develops products based on gene-editing with a portfolio of allogeneic chimeric antigen receptor T-cells product candidates.

Neumora Therapeutics

Market Cap: US$107.2m

A clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases, neuropsychiatric disorders, and neurodegenerative diseases in the United States.

AB Science

Market Cap: €95.4m

A clinical-stage company, designs and develops novel drugs to various diseases with high unmet medical needs for inflammatory diseases, pathologies affecting peripheral and central nervous system, and cancers in France.

Atossa Therapeutics

Market Cap: US$105.5m

Operates as a clinical-stage biopharmaceutical company that develops medicines in the areas of unmet medical need in oncology for women breast cancer and other conditions in the United States.

Imugene

Market Cap: AU$164.3m

A clinical stage immuno-oncology company, develops a range of immunotherapies to activate the immune system of cancer patients to treat and eradicate tumours in Australia.